US Senators Thom Tillis (Republican – North Carolina) and Christopher A. Coons (Democrat – Deloware) sent a letter to the US Department of Justice (DOJ) pushing it to provide greater clarity as to its antitrust enforcement policy on standard essential patents (“SEPs”).
This week’s letter from Senators Tillis and Coons addresses a specific issue associated with SEPs, namely the licensing of SEPs on fair, reasonable, and nondiscriminatory (FRAND) terms.
In their letter, the Senators wrote, “stakeholders have expressed concerns regarding a growing divide between the Department, the Federal Trade Commission, and the USPTO (United States Patent and Trademark Office) about the role of antitrust laws should play in addressing SEPs and FRAND commitments.” The letter encourages DOJ to work with the USPTO to develop a revised policy statement regarding SEP licensing.
SEPs are patents necessary for certain technological standards set by standard setting organizations. One example of the impact of technological standards on our daily lives involve cell phones, without consensus and collaboration between manufacturers, 3G, 4G, and now 5G, mobile networks would not be feasible. That said, SEPs can give rise to antitrust risks, reported JD Supra. For example, firms holding patents integrated into technological standards can wield significant leverage over their potential competitors by refusing to give access to the patents necessary to compete.
The US antitrust agencies have expressed differing views as to SEPs. The FTC and DOJ have adopted opposing positions at times, and there have even been internal inconsistencies within the agencies. Makan Delrahim has been particularly vocal on the topic, expressing caution against overaggressive antitrust enforcement against SEP holders and highlighting the need to encourage innovation by protecting intellectual property rights.
Full Content: JD Supra
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
FTC Takes On Prescription Drug Middlemen Over High Insulin Costs
Sep 20, 2024 by
CPI
EU’s Incoming Competition Head Pushes for Policy Shift to Support ‘European Champions
Sep 19, 2024 by
CPI
Google Challenges $217 Million Legal Fee Demand in Privacy Case
Sep 19, 2024 by
CPI
EU Moves to Enforce Apple’s Compliance with New Market Rules
Sep 19, 2024 by
CPI
California Attorney General Bonta Stands Firm Against Albertsons-Kroger Merger
Sep 19, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Canada & Mexico
Sep 3, 2024 by
CPI
Competitive Convergence: Mexico’s 30-Year Quest for Antitrust Parity with its Northern Neighbor
Sep 3, 2024 by
Francisco Javier Núñez Melgoza
Competition and Digital Markets in North America: A Comparative Study of Antitrust Investigations in Mexico and the United States
Sep 3, 2024 by
Julio Garcia
Recent Antitrust Development in Mexico: COFECE’s Preliminary Report on Amazon and Mercado Libre
Sep 3, 2024 by
Alejandra Palacios Prieto
The Cost of Making COFECE Disappear
Sep 3, 2024 by
Mateo Fernández